206 related articles for article (PubMed ID: 10079373)
1. Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors.
Rathore A; Kamarajan P; Mathur M; Sinha S; Sarkar C
Pathol Oncol Res; 1999; 5(1):21-7. PubMed ID: 10079373
[TBL] [Abstract][Full Text] [Related]
2. Expression of retinoblastoma gene product and p21 (WAF1/Cip 1) protein in gliomas: correlations with proliferation markers, p53 expression and survival.
Korkolopoulou P; Kouzelis K; Christodoulou P; Papanikolaou A; Thomas-Tsagli E
Acta Neuropathol; 1998 Jun; 95(6):617-24. PubMed ID: 9650754
[TBL] [Abstract][Full Text] [Related]
3. Patterns of expression of Rb and p16 in astrocytic gliomas, and correlation with survival.
Puduvalli VK; Kyritsis AP; Hess KR; Bondy ML; Fuller GN; Kouraklis GP; Levin VA; Bruner JM
Int J Oncol; 2000 Nov; 17(5):963-9. PubMed ID: 11029499
[TBL] [Abstract][Full Text] [Related]
4. Roles of the functional loss of p53 and other genes in astrocytoma tumorigenesis and progression.
Nozaki M; Tada M; Kobayashi H; Zhang CL; Sawamura Y; Abe H; Ishii N; Van Meir EG
Neuro Oncol; 1999 Apr; 1(2):124-37. PubMed ID: 11550308
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and Ki-67 labelling in high grade astrocytomas treated with radiotherapy.
Kirla R; Salminen E; Huhtala S; Nuutinen J; Talve L; Haapasalo H; Kalimo H
J Neurooncol; 2000; 46(1):71-80. PubMed ID: 10896207
[TBL] [Abstract][Full Text] [Related]
6. [Relationship between p16 and Rb protein expression in astrocytomas].
Lin Y; Huang C; Liu D
Zhonghua Bing Li Xue Za Zhi; 1997 Dec; 26(6):340-2. PubMed ID: 10374322
[TBL] [Abstract][Full Text] [Related]
7. Pathways leading to glioblastoma multiforme: a molecular analysis of genetic alterations in 65 astrocytic tumors.
Lang FF; Miller DC; Koslow M; Newcomb EW
J Neurosurg; 1994 Sep; 81(3):427-36. PubMed ID: 8057151
[TBL] [Abstract][Full Text] [Related]
8. [Study on the expression of epidermal growth factor receptor and p53 in astrocytic gliomas: evidence for a distinct genetic pathway].
Dong L; Pu PY; Wang H; Wang GX; Kang CS; Jiao DR
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):232-6. PubMed ID: 16776982
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity of the Rb gene correlates with pRb protein expression and associates with p53 alteration in human esophageal cancer.
Xing EP; Yang GY; Wang LD; Shi ST; Yang CS
Clin Cancer Res; 1999 May; 5(5):1231-40. PubMed ID: 10353761
[TBL] [Abstract][Full Text] [Related]
10. Prognostic relevance of transforming genes.
Schlegel U; Neumann J; Kindermann D; Wolf HK; Baumann A; Forster F; Fimmers R
Recent Results Cancer Res; 1994; 135():43-53. PubMed ID: 8047696
[No Abstract] [Full Text] [Related]
11. Altered structure and expression of the p53 gene in human neuroepithelial tumors.
Tabuchi K; Fukuyama K; Mineta T; Oh-Uchida M; Hori K
Neurol Med Chir (Tokyo); 1992 Sep; 32(10):725-32. PubMed ID: 1280773
[TBL] [Abstract][Full Text] [Related]
12. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses.
Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H
Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587
[TBL] [Abstract][Full Text] [Related]
13. p53 and PTEN gene mutations in gemistocytic astrocytomas.
Watanabe K; Peraud A; Gratas C; Wakai S; Kleihues P; Ohgaki H
Acta Neuropathol; 1998 Jun; 95(6):559-64. PubMed ID: 9650746
[TBL] [Abstract][Full Text] [Related]
14. No complementation between TP53 or RB-1 and v-src in astrocytomas of GFAP-v-src transgenic mice.
Maddalena AS; Hainfellner JA; Hegi ME; Glatzel M; Aguzzi A
Brain Pathol; 1999 Oct; 9(4):627-37. PubMed ID: 10517501
[TBL] [Abstract][Full Text] [Related]
15. p53 protein and epidermal growth factor receptor expression in human astrocytomas.
Kordek R; Biernat W; Alwasiak J; Maculewicz R; Yanagihara R; Liberski PP
J Neurooncol; 1995 Oct; 26(1):11-6. PubMed ID: 8583240
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic alterations in glioblastomas with oligodendroglial component.
Kraus JA; Lamszus K; Glesmann N; Beck M; Wolter M; Sabel M; Krex D; Klockgether T; Reifenberger G; Schlegel U
Acta Neuropathol; 2001 Apr; 101(4):311-20. PubMed ID: 11355302
[TBL] [Abstract][Full Text] [Related]
17. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas.
Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW
Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140
[TBL] [Abstract][Full Text] [Related]
18. Alterations of the p53 and pRB pathways in human astrocytoma.
Rutka JT; Akiyama Y; Lee SP; Ivanchuk S; Tsugu A; Hamel PA
Brain Tumor Pathol; 2000; 17(2):65-70. PubMed ID: 11210173
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma.
Nakamura M; Konishi N; Tsunoda S; Hiasa Y; Tsuzuki T; Inui T; Sakaki T
Cancer; 1997 Jul; 80(2):242-9. PubMed ID: 9217037
[TBL] [Abstract][Full Text] [Related]
20. Primary and secondary glioblastomas: from concept to clinical diagnosis.
Kleihues P; Ohgaki H
Neuro Oncol; 1999 Jan; 1(1):44-51. PubMed ID: 11550301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]